Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Type 2 Diabetes Mellitus.”

Showing 20 of 0 results

Not applicableStudy completedNCT00839878
What this trial is testing

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Bangladesh

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 2,092
Testing effectiveness (Phase 2)Study completedNCT03655535
What this trial is testing

Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes

Who this might be right for
Type2 Diabetes Mellitus
Boston Therapeutics 66
Large-scale testing (Phase 3)Study completedNCT02947620
What this trial is testing

Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)

Who this might be right for
Type II DiabetesDyslipidemia
Daewoong Pharmaceutical Co. LTD. 185
Large-scale testing (Phase 3)Study completedNCT02791490
What this trial is testing

The Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 458
Testing effectiveness (Phase 2)Study completedNCT02405260
What this trial is testing

Add Glucokinase Activator to Target A1c

Who this might be right for
Diabetes Mellitus, Type 2
vTv Therapeutics 190
Testing effectiveness (Phase 2)Study completedNCT00085969
What this trial is testing

Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 99
Not applicableStudy completedNCT00803296
What this trial is testing

Incretin Effect in Lean and Obese Subjects

Who this might be right for
Incretin EffectInsulin ResistanceType 2 Diabetes
University Hospital, Gentofte, Copenhagen 32
Post-approval studies (Phase 4)Study completedNCT01425359
What this trial is testing

Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina

Who this might be right for
Angina PectorisCoronary Artery DiseaseType 2 Diabetes Mellitus
Gilead Sciences 949
Large-scale testing (Phase 3)Study completedNCT00467376
What this trial is testing

Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Sanofi 485
Early research (Phase 1)Study completedNCT00115973
What this trial is testing

The Treatment of Type 2 Diabetes With an Insulin Infusion Pump

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Delivery Systems
Novo Nordisk A/S 71
Large-scale testing (Phase 3)Active Not RecruitingNCT06767761
What this trial is testing

A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated With Basal + Prandial Insulin

Who this might be right for
Diabetes
Gan & Lee Pharmaceuticals. 580
Post-approval studies (Phase 4)Study completedNCT02220920
What this trial is testing

Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Tanabe Pharma Corporation 146
Not applicableStudy completedNCT01038089
What this trial is testing

Pilot Study Of The Effects Of Resveratrol On Endothelial Function In Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Boston University 20
Early research (Phase 1)UnknownNCT02817217
What this trial is testing

The DDI Study of SP2086 and Valsartan

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 24
Early research (Phase 1)Study completedNCT00519480
What this trial is testing

Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 50
Early research (Phase 1)Study completedNCT05497674
What this trial is testing

Effects of Rifampicin and Probenecid On The Pharmacokinetic Profile Of Rongliflozin In Healthy Subjects

Who this might be right for
Type 2 Diabetes Mellitus
Sunshine Lake Pharma Co., Ltd. 28
Large-scale testing (Phase 3)Study completedNCT03173391
What this trial is testing

Long-term Efficacy and Safety of HMS5552 in T2DM Subjects

Who this might be right for
Diabetes Mellitus, Type 2
Hua Medicine Limited 463
Large-scale testing (Phase 3)Study completedNCT00849017
What this trial is testing

Safety and Efficacy Study of Albiglutide in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 309
Not applicableStudy completedNCT01579981
What this trial is testing

The Importance of GLP-1 in Post RYGB Improvement in Glycaemic Control Type 2 Diabetic Subjects

Who this might be right for
Type 2 Diabetes
Hvidovre University Hospital 9
Testing effectiveness (Phase 2)Study completedNCT03751657
What this trial is testing

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 247
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation